The top 10 cellular analysis market is expected to reach USD 41.34 Billion by 2021 from USD 28.66 Billion in 2016, at a CAGR of 7.6% during the forecast period.
Cellular analysis is used for cell identification, cell interaction, cell viability, cell proliferation, cell structure study, cell signaling/cell transduction, target identification & validation, cell counting, and quality control. Currently, cellular analysis technologies are used in various phases of the drug discovery process, cancer diagnosis (oncology), blood cell analysis, toxicity testing, personalized medicine, pathogen testing, and other applications. In addition, cellular analysis technologies are extensively used in research institutes for understanding the evolution and development process of various types of cells.
Growth in the market is primarily driven by the availability of corporate and government funding for cell-based research and rising incidence of chronic and infectious diseases. The introduction of technologically advanced products for cell analysis, growing life sciences industry, and increase in healthcare spending are the other factors supporting the growth of this market. However, high installation and implementation costs of cell analysis systems and stringent regulations for their approval are expected to hinder the growth of this market.
Based on technology, the top 10 cellular analysis market is segmented into cell imaging techniques, flow cytometry, spectrophotometry, polymerase chain reaction (PCR), cell counting, blotting, high-content screening, sample preparation technologies, cell microarray technology, and centrifugation. The cell imaging techniques segment dominates the market in 2016. Factors expected to drive the cell imaging techniques market are rising investments in life sciences research and introduction of technologically advanced cell imaging instruments for cell analysis procedures.
On the basis of application, the market is segmented into biopharmaceutical applications, cancer research, stem cell research, tissue engineering and regenerative medicine, and other applications (organ cultures, IVF, virology, in vitro diagnostics, and genetic counselling). In 2016, the biopharmaceutical applications segment is expected to account for the largest share of the market. The large share of this segment can be attributed to the increasing investments by companies for the production of biopharmaceutical products.
On the basis of end user, the market is segmented into hospitals and diagnostic laboratories, research laboratories and institutes, cell banks, biotechnology and pharmaceutical companies, and other end users (food and beverage manufacturers, environmental monitoring organizations, forensic laboratories, and blood banks). The hospitals and diagnostic laboratories segment is expected to account for the largest share of the top 10 cellular analysis market in 2016. Some of the major factors driving the growth of this segment include increasing incidence of chronic and infectious diseases and increasing investments in healthcare systems across the globe.
- Agilent Technologies, Inc.
- Beckman Coulter Inc. (A Subsidiary of Danaher Corporation)
- Becton, Dickinson And Company
- Bio-Rad Laboratories, Inc.
- Ge Healthcare
- Merck Kgaa
- Nikon Corporation
- Olympus Corporation
- Tecan Group Ltd.
- Thermo Fisher Scientific, Inc.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Global Top 10 Cellular Analysis Market, By Technology
8 Top 10 Cellular Analysis Market, By Application
9 Top 10 Cellular Analysis Market, By End User
10 Global Top 10 Cellular Analysis Market, By Region
11 Competitive Landscape
12 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/8bwq4z/top_10_cellular
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-top-10-cellular-analysis-market-to-reach-4134-billion-by-2021-driven-by-availability-of-corporate--government-funding-for-cell-based-research---research-and-markets-300397350.html
SOURCE Research and Markets